The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO Asia 2025 | Multidisciplinary team maturity and gaps in hepatocellular carcinoma care
Stephen Lam Chan, MD, FRCP, Chinese University of Hong Kong, Hong Kong, China, discusses a qualitative assessment from the Multidisciplinary Team (MDT) Aid Program evaluating MDT practices in hepatocellular carcinoma across selected countries in Asia, the Middle East, Africa and Latin America. Using surveys and structured workshops, the initiative identified strengths in clinical processes, team culture and expertise, alongside gaps in technology, access and quality assurance. More mature, structured multidisciplinary teams are perceived to improve treatment coordination, patient outcomes and care efficiency. This interview took place at 2025 European Society for Medical Oncology (ESMO) Asia Congress in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
So there’s a poster presentation on the quality, the self-evaluated quality of the different multidisciplinary tumor boards in different countries. So we try to assess the score on the different aspects of the tumor board, which ranged from like the professionalism, the quality, the referral basis, or the maturity and the culture, and also the auditing quality assurance of the different MDTs...
So there’s a poster presentation on the quality, the self-evaluated quality of the different multidisciplinary tumor boards in different countries. So we try to assess the score on the different aspects of the tumor board, which ranged from like the professionalism, the quality, the referral basis, or the maturity and the culture, and also the auditing quality assurance of the different MDTs. The key result was that there’s a variable maturity or different score for different domains. Most of the MDTs, they score highly for the professional knowledge, communication, or the patient referral. The weaker aspects were those like quality assurance and also some of the selection of patients for the MDT. So this means that there is potential room for improvement in the quality of the MDTs for the MDTs. And this is particularly important when we have different modalities of treatment and also different pathways of the patient.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
